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Objective: The objective of this study was to evaluate the impact of contrast medium volume, inferior mesenteric artery
(IMA) patency, and pre-existing as well as new-onset thrombus on the inﬂammatory response after elective endovascular
aneurysm repair (EVAR).
Methods: The study included 87 patients undergoing elective endovascular repair of asymptomatic infrarenal aneurysms
between January 2011 and November 2011. The patency of the IMA was determined by preoperative computed to-
mography angiography; the volume of the contrast medium used during the procedure was measured, and the volumes of
chronic mural as well as new-onset thrombus were calculated from the preoperative and postoperative computed to-
mography angiograms with dedicated imaging software. The results were correlated to the occurrence of post-
implantation syndrome (PIS) as well as to the main clinical and laboratory components of PIS: fever; increased white
blood cell (WBC) count and C-reactive protein (CRP) level; decreased platelet count; and increased interleukin (IL)-6,
IL-8, and IL-10 levels.
Results: Postoperatively, a statistically signiﬁcant increase was recorded in the mean values of body temperature, WBCs,
CRP, IL-6, IL-8, and IL-10, and a statistically signiﬁcant decrease was recorded in the number of platelets. After
adjustment for endograft type, the volume of new-onset thrombus was found to be signiﬁcantly correlated with the peak
postoperative temperature (b[ .307; P < .05) and the increase in WBC count (b[ .271; P < .05), CRP level (b[ .484;
P < .001), and IL-6 level (b[ .288; P < .05). On the contrary, the volume of chronic mural thrombus, the patency of the
IMA, and the volume of contrast medium were not found to signiﬁcantly affect any parameter of the PIS. PIS occurred in
34 patients (39%). Multiple logistic regression analysis showed that both the volume of new-onset thrombus and the type
of endograft were independently associated with the development of PIS.
Conclusions: The volume of new-onset thrombus is associated with the development of PIS after EVAR, whereas chronic
mural thrombus appears to be an inert material. IMA patency and contrast medium volume are irrelevant to the in-
ﬂammatory response after EVAR. (J Vasc Surg 2014;60:1140-5.)Postimplantation syndrome (PIS) is a common clinical
entity occurring in 18% to 100% of patients after endovas-
cular aneurysm repair (EVAR).1-5 The wide variation in the
reported incidence of the syndrome may be due, at least in
part, to the lack of a unanimously accepted deﬁnition of the
syndrome. The deﬁnition of PIS as fever coinciding with
a rise in inﬂammatory markers1 neither sets cutoff values
of fever nor deﬁnes speciﬁc inﬂammatory markers, so
various combinations of fever, leukocytosis, and elevated
C-reactive protein (CRP) have been used in the literature.1-5the Department of Vascular Surgerya and Department of Cytopatho-
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0The etiology of PIS is even less clear. Stent graft
composition has been identiﬁed as the most important fac-
tor determining the incidence and severity of PIS, with
stent grafts based on woven polyester being independently
associated with a stronger inﬂammatory response.1,6,7 The
fact, however, that the inﬂammatory response is not of the
same magnitude in all patients treated with the same type
of endograft indicates that other factors, apart from stent
graft composition, are involved in the pathogenesis
of PIS. Injury of the endothelium during implantation,
bacterial translocation due to transient sigmoid ischemia,
contrast medium-induced neutrophil degranulation, endo-
vascular instrumentation of the mural thrombus, and
thrombosis of the aneurysm sac after aneurysm exclusion
have been proposed as factors triggering the pathophysio-
logic process leading to PIS.7-12
In a previous study with this same group of patients, we
had demonstrated that the type of endograft plays a pivotal
role in the inﬂammatory response after EVAR.7 The aim of
the present study was to evaluate the impact of contrast
medium volume, inferior mesenteric artery (IMA) patency,
and pre-existing as well as new-onset thrombus on the
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pose, we used the laboratory data already collected in our
previous study and performed a separate analysis corre-
lating them with the potential predictors of PIS mentioned
before.
METHODS
Study sample. Between January 2011 and November
2011, a total of 100 patients underwent elective endovas-
cular repair of asymptomatic infrarenal abdominal aortic
aneurysms in our department. Thirteen patients were
excluded from the study because of recent (<15 days)
pulmonary infection (2 patients), surgical operation within
the last 2 months (2 patients), history of autoimmune
disorder under anti-inﬂammatory or immunodepressant
agents (5 patients), and history of malignant disease
(4 patients). Informed consent was obtained from all
study participants, and the study protocol was approved by
the Institutional Review Board.
Endovascular procedure. All patients were submitted
to preoperative computed tomography angiography (CTA)
with three-dimensional reconstruction. The choice of graft
was based on the anatomic characteristics of the aneurysm:
the Anaconda endograft (Vascutek Terumo, Renfrewshire,
Scotland) was used in 28 patients, the Zenith endograft
(Cook Medical, Bloomington, Ind) in 26, the Excluder
endograft (W. L. Gore & Associates, Flagstaff, Ariz) in 23,
and the Endurant endograft (Medtronic, Minneapolis,
Minn) in 10 patients. All of them were bifurcated aorto-
bi-iliac grafts introduced by femoral cutdown.
The procedures were performed under either gen-
eral or epidural anesthesia, depending on the patients’
comorbidities.
Medications. Antiplatelets were discontinued and
switched to low-molecular-weight heparin in patients
scheduled for epidural anesthesia. Antiplatelets were started
again on the second postoperative day, after removal of the
epidural catheter. Almost one third of the patients were
receiving statins on admission. The remaining two thirds
were started on statin therapy on the day of admission. All
patients received perioperative antibiotic prophylaxis with
intravenous vancomycin (1 g) and piperacillin plus tazo-
bactam (4.5 g) administered 1 hour before and 12 hours
after the operation. Systemic heparinization was achieved
with 5000 IU of heparin, and the same nonionic contrast
medium was used in all procedures (iobitridol, 300 mg
iodine/mL). Prophylactic anticoagulation with 3500 IU of
tinzaparin was administered from the ﬁrst postoperative
day until the day of discharge. No postoperative anti-
inﬂammatory drugs were administered to the patients.
Pain and fever were treated with acetaminophen.
Blood samples and laboratory evaluation. Blood
samples were obtained 24 hours before the operation and
24 and 48 hours after the endovascular procedure. Serum
concentrations of interleukin (IL)-6, IL-8, and IL-10
were determined with the Milliplex High Sensitivity
Cytokine/Chemokine kit (Millipore Corp, Billerica, Mass)
according to the manufacturer’s instructions. The numberof white blood cells (WBCs) and platelets (PLTs) and the
levels of CRP were also measured at the same time points.
IMA patency and volume measurements. The
patency of the IMA was determined by preoperative
CTA and was recorded as patent or occluded.
The volume of chronic mural thrombus as well as the
volume of new-onset thrombus was calculated by the OsiriX
imaging software (v3.9.1; OsiriX Medical Image Software,
Geneva, Switzerland). The closed polygon tool was used
to outline the perimeter of the aneurysm sac on every trans-
verse slice of the CTA starting from the level of the renal ar-
teries and ending at the aortic bifurcation. With this input,
the software automatically calculated the volume of the
aneurysm sac. When the aneurysm extended to the iliac ar-
teries, the volume of each iliac artery was calculated in the
same way and was added to the whole aneurysm sac volume.
The volume of the true lumen was then calculated in the
same semiautomatic way (Fig) and was deducted from the
whole aneurysm sac volume. The product of the deduction
represents the volume of the chronic mural thrombus.
All of the patients were submitted to CTA within the
ﬁrst postoperative month. The volume of the endograft
was measured and was deducted from the luminal volume
that had been measured on preoperative CTA, as already
described. The product of the deduction represents the
volume of the new-onset thrombus, provided there is no
endoleak. In cases of endoleak, the endoleak cavity volume
was measured in the same way and was deducted from the
initial luminal volume.
Data collection and statistical analysis. Demo-
graphics (age, gender), risk factors (hypertension, dyslipide-
mia, diabetes mellitus, smoking, coronary artery disease,
chronic obstructive pulmonary disease), statin and antiplate-
let use, aneurysm diameter, IMA patency, type of endograft,
operative time (time from incision to skin closure), contrast
medium volume, type of anesthesia, presence of endoleak at
ﬁrst-month follow-up, volume of old as well as new-onset
thrombus, maximum postoperative tympanic temperature
(recorded after routine measurements in 4-hour intervals
during the patients’ hospital stay), number of WBCs and
PLTs, and levels of CRP, IL-6, IL-8, and IL-10 were
recorded and used in the analysis. PIS was deﬁned as tem-
perature >38C and leukocytosis >12,000/mL in the
absence of infection.13
Continuous variables are presented as means 6 stan-
dard deviation, whereas categorical variables are presented
as counts and percentages. To test the association between
potential predictors of PIS (including chronic mural
thrombus or new-onset thrombus, amount of contrast me-
dium, and IMA patency) with the various components of
PIS (temperature, WBCs, PLTs, CRP, and the IL levels),
the Pearson correlation coefﬁcient (Pearson r) was calcu-
lated. All tests were two sided, and results were considered
statistically signiﬁcant when the P value was < .05. Multiple
linear regression analysis, including all factors that were
found to be of prognostic signiﬁcance in univariate ana-
lyses, was applied to detect independence of associations
with the aforementioned components of PIS. The Student
Table I. Patients’ characteristics at baseline (N ¼ 87)
Baseline characteristic No. of patients %
Age, years (mean 6 SD) 72.6 6 5.7
Maximum diameter, cm (mean 6 SD) 5.46 6 0.68
Men 81 93
Coronary artery disease 28 32
Hypertension 48 55
Chronic obstructive pulmonary disease 17 20
Dyslipidemia 24 28
Diabetes mellitus 13 15
Smoking 33 38
Statins on admission 24 28
Antiplatelets 29 33
Aspirin 18 21
Clopidogrel 11 13
Patent IMA 61 70
IMA, Inferior mesenteric artery; SD, standard deviation.
Table II. Laboratory data preoperatively and
postoperatively (mean 6 SD)
Variable
Preoperative
value
Peak postoperative
value P
WBCs  103/mL 7.1 6 1.5 12.8 6 3.4 <.001
PLTs  103/mL 192 6 31 161 6 33 <.001
CRP, mg/L 3.1 6 2.1 93.1 6 44.9 <.001
IL-6, pg/mL 4.5 6 3.7 82.2 6 90.6 <.001
IL-8, pg/mL 21.1 6 20.5 50.6 6 71.8 .001
IL-10, pg/mL 7.6 6 6.1 42.9 6 59.5 <.001
CRP, C-reactive protein; IL, interleukin; PLTs, platelets; SD, standard
deviation; WBCs, white blood cells.
Fig. Luminal volume calculation by the closed polygon tool of the
OsiriX imaging software: manual outlining of the perimeter of the
true lumen (A) with subsequent automatic volume calculation (B).
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of continuous variables between patients with and without
PIS, whereas the c2 test was used to determine associations
between categorical variables and PIS. Multiple logistic
regression analysis was applied to detect independence of
associations. Statistical analysis was performed with use of
the SPSS 19 software (IBM Corp, Somers, NY).
RESULTS
Patient characteristics at baseline are depicted in
Table I. Endograft deployment was successfully achieved
in all patients with no need for open conversion. Mean
operative time was 56.36 28.6 minutes, and mean volume
of contrast medium was 178.6 6 46.7 mL.No major postoperative complication occurred. Minor
complications included local hematomas in groin incisions
in three patients that were treated conservatively. Type II
endoleaks were noted in 12 patients (14%) on CTA in
the ﬁrst postoperative month, whereas no type I, III, or
IV endoleak was found.
Postoperatively, mean temperature increased from
36.9 6 0.3C to 38.0 6 0.5C (P < .001). None of
the patients had clinical signs of infection. Preoperative
and postoperative laboratory data are shown in Table II.
A statistically signiﬁcant increase was found in the mean
values of WBCs, CRP, IL-6, IL-8, and IL-10, and a statis-
tically signiﬁcant decrease was found in the number of
PLTs.
No statistically signiﬁcant correlation was found be-
tween any of the preoperative patients’ characteristics
depicted in Table I (including maximum aneurysm diam-
eter, patency of the IMA, and use of statins) and the
peak postoperative temperature, the increase in WBC
count, the decrease in PLT count, and the increase in
CRP, IL-6, IL-8, and IL-10 levels.
No statistically signiﬁcant correlation was also found
between the intraoperative parameters assessed in this
study (operative time and volume of contrast medium)
and any of the aforementioned components of the PIS.
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63.7 6 73.6 mL, and the mean volume of new-onset
thrombus was 55.1 6 74.8 mL. A statistically signiﬁcant
correlation was found between the volume of new-onset
thrombus and peak postoperative temperature (r ¼ .379;
P < .01) as well as the increase in WBC count (r ¼
.368; P ¼ .01), CRP level (r ¼ .533; P < .001), and IL-
6 level (r ¼ .380; P ¼ .01). On the contrary, the volume
of chronic mural thrombus was not found to signiﬁcantly
affect any parameter of PIS. Multivariate analysis, including
the volume of new-onset thrombus and the type of endog-
raft, veriﬁed that the volume of new-onset thrombus was
independently associated with peak postoperative tempera-
ture (b ¼ .306; P < .05) and the increase in WBC count
(b ¼ .275; P < .05), CRP level (b ¼ .473; P < .001),
and IL-6 level (b ¼ .276; P < .05).
PIS occurred in 34 patients (39%) with a wide variance
among the various graft types: 13% (3 patients) in the
Excluder endograft, 20% (2 patients) in the Endurant,
35% (9 patients) in the Zenith, and 71% (20 patients) in
the Anaconda endograft (P < .001).
No statistically signiﬁcant correlation was found be-
tween the development of PIS and any of the preoperative
patients’ characteristics or any of the intraoperative param-
eters assessed in this study (operative time and volume of
contrast medium). The volume of new-onset thrombus
was signiﬁcantly higher in patients with PIS (92.5 6
101.6 mL vs 31.2 6 32.5 mL; P < .001), whereas no sta-
tistically signiﬁcant difference was found in the volume of
chronic mural thrombus between patients with and
without PIS. Multiple logistic regression analysis veriﬁed
that both the volume of new-onset thrombus and the
type of endograft were independently associated with the
development of PIS.DISCUSSION
The notion that thrombosis may cause fever is not new.
Several studies have shown that fever is relatively common
in patients with acute deep venous thrombosis (DVT) or
pulmonary embolism,14,15 that it may be the presenting
symptom of postoperative DVT,16 or that DVT may be
the underlying cause of fever of unknown origin.17 Soft tis-
sue hematomas may also cause fever, known as absorption
fever.18,19 These ﬁndings prompted us to test the hypoth-
esis that new-onset thrombus within the aneurysm sac is
associated with PIS developing after EVAR. The results
of the study veriﬁed that new-onset thrombus is associated
with the main symptom of PIS (fever), the main laboratory
ﬁndings (WBC and CRP elevation), and the pathophysio-
logic process mediating PIS (IL elevation).
The link between thrombosis and inﬂammation is also
not new. Emerging data in the literature suggest that prod-
ucts released from PLTs during thrombosis are actively
involved in the inﬂammatory response within the vessel
wall and that PLTs are a primary source of inﬂammatory
proteins, such as RANTES (regulated on activation,
normal T-cell expressed and secreted) and CD40L.20Adherence of these inﬂammatory proteins to the endothelial
cells is followed by reactive oxygen species, chemokine and
cytokine production, and recruitment of leukocytes.20-25
Although clariﬁcation of the exact mechanism of action of
acute thrombus causing PIS is beyond the scope of this
manuscript, the ﬁndings of our study could be explained
by the aforementioned pathophysiologic process.
On the other hand, the amount of pre-existing mural
thrombus within the aneurysm sac was not found to have
any association with the development of PIS. This ﬁnding
weakens the theory that the source of ILs released during
the endovascular procedure is the mural thrombus of the
abdominal aortic aneurysm.15 The theory was based on
the ﬁnding that mural thrombus of an aortic aneurysm
contains high amounts of IL-6.26 It was therefore specu-
lated that manipulations with introducers and catheters in-
side the mural thrombus might release IL-6 and stimulate
WBCs to produce tumor necrosis factor a, a mediator of
the systemic inﬂammatory response.17,18,26,27 Other ﬁnd-
ings of the present study opposing the aforementioned the-
ory are the lack of an association between operative time
and PIS and the fact that the endograft associated with
the most severe inﬂammatory response is the Anaconda
endograft,7 which requires the least manipulation with
catheters and wires because of the contralateral limb cannu-
lation aid (magnet).28 However, the time of manipulations
within the aneurysm sac was not speciﬁcally measured, nor
was the severity of such manipulations quantiﬁed in some
other way.
Another potential cause of post-EVAR fever is bacterial
translocation due to transient sigmoid ischemia. Sigmoid
ischemia can be caused either by occlusion of a previously
patent IMA or by microembolization during catheter and
wire manipulations. In both cases, patency of the IMA is
a prerequisite for the sigmoid ischemia. Nevertheless, the
ﬁndings of our study showed that the patency of the
IMA does not affect the development of PIS. These ﬁnd-
ings are in line with the conclusion of a prospective clinical
trial showing that prolonging antibiotic treatment beyond
the day of endovascular intervention did not provide any
short- or long-term clinical beneﬁt in patients with PIS,
given that all the blood samples were sterile.11
The reason that we included statins in our analysis, as po-
tential predictors of the inﬂammatory response after EVAR,
is the fact that they have been found to modulate various
signaling pathways implicated in the development of inﬂam-
mation, as part of their so-called pleiotropic functions.29,30
However, because all of our patients received statins after
their admission to the hospital as part of our standard cardio-
vascular risk reduction protocol, the analysis is practically
limited to a comparison between chronic and perioperative
use of statins, which failed to show any difference.
The ﬁnding of the association between the woven poly-
ester endograft and the incidence and intensity of PIS is not
new; several groups, including ours, have demonstrated
this independent and strong relation.1,6,7 No other preop-
erative or intraoperative variable has been found to be of
prognostic signiﬁcance, with our study being the ﬁrst to
JOURNAL OF VASCULAR SURGERY
1144 Kakisis et al November 2014add a second prognostic indicator: the amount of new-
onset thrombus. The improvement of our ability to predict
the development of PIS raises the question of whether
there is actually a clinical need to predict the development
of a clinical entity that is rather benign and self-limited.
Although several authors fear that PIS may lead to an
adverse clinical outcome, there has been only one study
evidencing this fear by showing that two of 14 patients
who developed PIS after EVAR experienced a nonfatal
myocardial infarction on the ﬁrst postoperative day.2 Other
series, including ours, have failed to show any association
between PIS and postoperative complications.6,7 Neverthe-
less, the symptoms of PIS (fever, fatigue, anorexia), the
prolonged hospital stay because of these symptoms,2 and
the increased readmission rate13 cannot be disregarded or
underestimated.
CONCLUSIONS
The volume of new-onset thrombus is associated with
the development of PIS after EVAR, whereas chronic
mural thrombus appears to be an inert material with
respect to this inﬂammatory response. We postulate that
the release of high amounts of IL-6 is triggered by the for-
mation of fresh thrombus within the aneurysm sac after the
implantation of the endograft and that IL-6 mediates the
subsequent inﬂammatory response. The patency of the
IMA and the volume of contrast medium do not affect
the development of PIS.
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